Analysts Offer Predictions for RenaissanceRe FY2026 Earnings

Key Points

• FY2026 EPS estimates increased: DOWLING & PARTN raised its forecast for RenaissanceRe to $44.00 per share from $40.00, just below the $44.21 consensus estimate.
• Analyst sentiment remains cautious: The stock has six Buy, eleven Hold, and one Sell rating, with a consensus price target of $337.81.
• RenaissanceRe recently reported solid results: The company posted quarterly EPS of $12.92, revenue of $2.77 billion, a 23.10% return on equity, and a 23.65% net margin; shares recently traded near $331.

RenaissanceRe Holdings Ltd. (NYSE:RNR - Free Report) - DOWLING & PARTN upped their FY2026 earnings per share (EPS) estimates for shares of RenaissanceRe in a report released on Wednesday, October 7th. DOWLING & PARTN analyst N. Iacoviello now anticipates that the insurance provider will post earnings per share of $44.00 for the year, up from their previous forecast of $40.00. The consensus estimate for RenaissanceRe's current full-year earnings is $44.21 per share.

RenaissanceRe (NYSE:RNR - Get Free Report) last posted its earnings results on Tuesday, June 30th. The insurance provider reported $12.92 earnings per share for the quarter. RenaissanceRe had a return on equity of 23.10% and a net margin of 23.65%. The business had revenue of $2.77 billion during the quarter.

A number of other equities analysts have also commented on RNR. Royal Bank Of Canada began coverage on shares of RenaissanceRe in a research note on Tuesday, September 22nd. They set a "sector perform" rating and a $365.00 price objective for the company. TD Cowen upped their target price on shares of RenaissanceRe from $300.00 to $315.00 and gave the stock a "hold" rating in a report on Tuesday, July 7th. Evercore set a $330.00 target price on shares of RenaissanceRe in a research note on Thursday, July 23rd. Bank of America increased their target price on shares of RenaissanceRe from $410.00 to $438.00 and gave the stock a "buy" rating in a research note on Thursday, July 23rd. Finally, Keefe, Bruyette & Woods raised their price target on shares of RenaissanceRe from $342.00 to $350.00 and gave the company a "market perform" rating in a report on Monday, July 27th. Six research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, RenaissanceRe currently has an average rating of "Hold" and a consensus target price of $337.81.

RenaissanceRe Trading Down 0.1%

Shares of RenaissanceRe stock opened at $331.14 on Monday. RenaissanceRe has a 12-month low of $231.17 and a 12-month high of $340.24. The company has a market cap of $13.76 billion, a price-to-earnings ratio of 5.68, a PEG ratio of 0.95 and a beta of 0.12. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.21. The company's 50-day moving average price is $325.54 and its 200-day moving average price is $312.46.

RenaissanceRe Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th were given a dividend of $0.41 per share. This represents a $1.64 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Tuesday, September 15th. RenaissanceRe's dividend payout ratio (DPR) is 2.81%.

Insider Activity

In other news, EVP Robert Qutub sold 5,000 shares of the business's stock in a transaction dated Tuesday, July 28th. The stock was sold at an average price of $333.03, for a total transaction of $1,665,150.00. Following the completion of the transaction, the executive vice president owned 72,907 shares of the company's stock, valued at approximately $24,280,218.21. The trade was a 6.42% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 2.30% of the company's stock.

Institutional Investors Weigh In On RenaissanceRe

A number of institutional investors and hedge funds have recently bought and sold shares of RNR. Elevation Wealth Partners LLC lifted its position in RenaissanceRe by 90.0% in the third quarter. Elevation Wealth Partners LLC now owns 95 shares of the insurance provider's stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. Continuum Advisory LLC purchased a new stake in shares of RenaissanceRe during the second quarter valued at approximately $38,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of RenaissanceRe in the second quarter worth approximately $42,000. Versant Capital Management Inc grew its holdings in shares of RenaissanceRe by 155.3% in the third quarter. Versant Capital Management Inc now owns 194 shares of the insurance provider's stock worth $62,000 after purchasing an additional 118 shares during the last quarter. Finally, IFP Advisors Inc grew its holdings in shares of RenaissanceRe by 29.4% in the second quarter. IFP Advisors Inc now owns 211 shares of the insurance provider's stock worth $67,000 after purchasing an additional 48 shares during the last quarter. 99.97% of the stock is owned by hedge funds and other institutional investors.

RenaissanceRe Company Profile

RenaissanceRe Holdings Ltd. is a Bermuda-based global provider of reinsurance and insurance solutions. Founded in 1993, the company focuses on managing and underwriting risks that can be difficult to place in traditional insurance markets, with an emphasis on disciplined underwriting and catastrophe risk management.

RenaissanceRe's business includes property catastrophe reinsurance, which provides coverage for events such as hurricanes, earthquakes and other natural disasters, as well as property, casualty and specialty reinsurance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.